Christophe Bauters

Q: What Schools Are Affiliated With Christophe Bauters

Christophe Bauters is affiliated with the following schools: University of California, Berkeley, Lille University of Science and Technology, Hannover Medical School, Stanford University, University of Lorraine

Christophe Bauters's AcademicInfluence.com Rankings

Christophe Bauters

Computer Science

#9328

World Rank

#9801

Historical Rank

Computational Linguistics

#2234

World Rank

#2257

Historical Rank

Machine Learning

#4052

World Rank

#4101

Historical Rank

Artificial Intelligence

#4391

World Rank

#4452

Historical Rank

computer-science Degrees

Download Badge

Computer Science

Christophe Bauters's Degrees

PhD Computer Science Stanford University
Masters Computer Science University of California, Berkeley
Bachelors Computer Science University of California, Berkeley

Similar Degrees You Can Earn

Why Is Christophe Bauters Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Christophe Bauters's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. (1998) (1241)
[Pathophysiology of coronary artery disease]. (2008) (723)
Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in vivo. (1995) (622)
Local delivery of vascular endothelial growth factor accelerates reendothelialization and attenuates intimal hyperplasia in balloon-injured rat carotid artery. (1995) (572)
Circulating Long Noncoding RNA, LIPCAR, Predicts Survival in Patients With Heart Failure (2014) (447)
The Circulating Long Non-Coding RNA LIPCAR Predicts Survival in Heart Failure Patients (2014) (340)
Restenosis rates in diabetic patients: a comparison of coronary stenting and balloon angioplasty in native coronary vessels. (1997) (304)
Predictors of restenosis after coronary stent implantation. (1998) (299)
Restenosis after coronary angioplasty. (1995) (247)
Gene transfer of naked DNA encoding for three isoforms of vascular endothelial growth factor stimulates collateral development in vivo. (1996) (230)
The biology of restenosis. (1997) (225)
Polymorphisms in the promoter regions of MMP-2, MMP-3, MMP-9 and MMP-12 genes as determinants of aneurysmal coronary artery disease. (2002) (225)
Hypercholesterolemia attenuates angiogenesis but does not preclude augmentation by angiogenic cytokines. (1997) (218)
Influence of diabetes mellitus on heart failure risk and outcome (2003) (212)
Site-specific therapeutic angiogenesis after systemic administration of vascular endothelial growth factor. (1995) (204)
Six-month angiographic outcome after successful repeat percutaneous intervention for in-stent restenosis. (1998) (199)
Left ventricular remodeling after anterior wall acute myocardial infarction in modern clinical practice (from the REmodelage VEntriculaire [REVE] study group). (2006) (193)
Impact of diabetes mellitus on long-term survival in patients with congestive heart failure. (2004) (189)
D allele of the angiotensin I-converting enzyme is a major risk factor for restenosis after coronary stenting. (1997) (170)
Therapeutic angiogenesis following arterial gene transfer of vascular endothelial growth factor in a rabbit model of hindlimb ischemia. (1996) (168)
Coronary angioscopic findings in the infarct-related vessel within 1 month of acute myocardial infarction: natural history and the effect of thrombolysis. (1998) (167)
Physiological assessment of augmented vascularity induced by VEGF in ischemic rabbit hindlimb. (1994) (160)
Recovery of disturbed endothelium-dependent flow in the collateral-perfused rabbit ischemic hindlimb after administration of vascular endothelial growth factor. (1995) (151)
Evidence for time-dependent activation of monocytes in the systemic circulation in unstable angina but not in acute myocardial infarction or in stable angina. (1994) (149)
Long‐Term Oral Administration of L‐ Arginine Reduces Intimal Thickening and Enhances: Neoendothelium‐Dependent Acetylcholine‐Induced Relaxation After Arterial Injury (1994) (141)
Effects of coronary stenting on vessel patency and long-term clinical outcome after percutaneous coronary revascularization in diabetic patients. (2002) (133)
Patency of Percutaneous Transluminal Coronary Angioplasty Sites at 6-Month Angiographic Follow-Up: A Key Determinant of Survival in Diabetics After Coronary Balloon Angioplasty (2001) (132)
B-type natriuretic peptide and peak exercise oxygen consumption provide independent information for risk stratification in patients with stable congestive heart failure. (2004) (126)
Association between beta-1 and beta-2 adrenergic receptor gene polymorphisms and the response to beta-blockade in patients with stable congestive heart failure (2005) (126)
Mechanisms and prevention of restenosis: from experimental models to clinical practice. (1996) (124)
The angiotensin II type 1 receptor gene polymorphism is associated with coronary artery vasoconstriction. (1997) (120)
Time course of increased cellular proliferation in collateral arteries after administration of vascular endothelial growth factor in a rabbit model of lower limb vascular insufficiency. (1995) (117)
Echocardiography predictors and prognostic value of pulmonary artery systolic pressure in chronic organic mitral regurgitation (2010) (109)
Restenosis, late vessel occlusion and left ventricular function six months after balloon angioplasty in diabetic patients. (1999) (103)
Circulating miR-133a and miR-423-5p fail as biomarkers for left ventricular remodeling after myocardial infarction. (2013) (103)
Percutaneous transluminal coronary rotary ablation with Rotablator (European experience). (1992) (103)
Effect of ACE inhibitors on angiographic restenosis after coronary stenting (PARIS): a randomised, double-blind, placebo-controlled trial (2001) (98)
Prognosis of patients with stable coronary artery disease (from the CORONOR study). (2014) (94)
Usefulness of serial assessment of B-type natriuretic peptide, troponin I, and C-reactive protein to predict left ventricular remodeling after acute myocardial infarction (from the REVE-2 study). (2010) (94)
Incidence, source, determinants, and prognostic impact of major bleeding in outpatients with stable coronary artery disease. (2014) (91)
Two-year outcome of patients after a first hospitalization for heart failure: A national observational study. (2014) (90)
Left ventricular abnormal response during dynamic exercise in patients with heart failure and preserved left ventricular ejection fraction at rest. (2008) (89)
Prognostic impact of matrix metalloproteinase gene polymorphisms in patients with heart failure according to the aetiology of left ventricular systolic dysfunction. (2003) (88)
Right Ventricular Systolic Function in Organic Mitral Regurgitation: Impact of Biventricular Impairment (2013) (84)
Preclinical Development of a MicroRNA-Based Therapy for Elderly Patients With Myocardial Infarction. (2016) (83)
High-sensitivity C-reactive protein: potential adjunct for risk stratification in patients with stable congestive heart failure. (2005) (81)
Characterisation of peripartum cardiomyopathy by cardiac magnetic resonance imaging (2008) (79)
The 5A6A polymorphism in the promoter of the stromelysin-1 (MMP3) gene as a risk factor for restenosis. (2002) (77)
Discordant results of visual and quantitative estimates of stenosis severity before and after coronary angioplasty. (1993) (75)
Combined antiplatelet therapy with ticlopidine and aspirin. A simplified approach to intracoronary stent management. (1996) (70)
Endothelial regrowth after arterial injury: from vascular repair to therapeutics. (1998) (70)
The impact of beta‐adrenoreceptor gene polymorphisms on survival in patients with congestive heart failure * (2005) (69)
First hospitalization for heart failure in France in 2009: patient characteristics and 30-day follow-up. (2013) (68)
Proto-oncogene expression in rabbit aorta after wall injury. First marker of the cellular process leading to restenosis after angioplasty? (1992) (68)
Long-Term Functional and Clinical Follow-Up of Patients With Heart Failure With Recovered Left Ventricular Ejection Fraction After &bgr;-Blocker Therapy (2014) (67)
Role of nitric oxide in restenosis after experimental balloon angioplasty in the hypercholesterolemic rabbit: effects on neointimal hyperplasia and vascular remodeling. (1999) (67)
Accumulation of fetal fibronectin mRNAs after balloon denudation of rabbit arteries. (1995) (63)
Relation of coronary angioscopic findings at coronary angioplasty to angiographic restenosis. (1995) (63)
Myocardial asynchronism is a determinant of changes in functional mitral regurgitation severity during dynamic exercise in patients with chronic heart failure due to severe left ventricular systolic dysfunction. (2006) (62)
Relation between the deletion polymorphism of the angiotensin-converting enzyme gene and late luminal narrowing after coronary angioplasty. (1995) (62)
Response of Human Coronary Arteries to Serotonin After Injury by Coronary Angioplasty (1993) (62)
Usefulness of circulating biomarkers for the prediction of left ventricular remodeling after myocardial infarction. (2012) (61)
Five-Year Risk of Major Ischemic and Hemorrhagic Events After Intracerebral Hemorrhage (2019) (59)
Effect of Ketanserin on Proximal and Distal Coronary Constrictor Responses to Intracoronary Infusion of Serotonin in Patients With Stable Angina, Patients With Variant Angina, and Control Patients (1992) (58)
Prevalence and determinants of cognitive impairment in chronic heart failure patients. (2007) (57)
High on‐treatment platelet reactivity with ticagrelor versus prasugrel: a systematic review and meta‐analysis (2015) (57)
The French Randomized Optimal Stenting Trial: a prospective evaluation of provisional stenting guided by coronary velocity reserve and quantitative coronary angiography. F.R.O.S.T. Study Group. (2000) (55)
Right ventricular systolic function for risk stratification in patients with stable left ventricular systolic dysfunction: comparison of radionuclide angiography to echoDoppler parameters. (2012) (54)
Local lesion-related factors and restenosis after coronary angioplasty. Evidence from a quantitative angiographic study in patients with unstable angina undergoing double-vessel angioplasty. (1995) (54)
Neointimal thickening after balloon denudation is enhanced by aldosterone and inhibited by spironolactone, and aldosterone antagonist. (1995) (53)
Association of angiotensin converting enzyme and angiotensin II type 1 receptor genotypes with left ventricular function and mass in patients with angiographically normal coronary arteries. (1997) (53)
Functional Impairment of Von Willebrand Factor in Hypertrophic Cardiomyopathy: Relation to Rest and Exercise Obstruction (2008) (52)
Clinical characteristics and angiographic follow-up of patients undergoing early or late repeat dilation for a first restenosis. (1992) (49)
The human G-protein beta3 subunit C825T polymorphism is associated with coronary artery vasoconstriction. (2001) (48)
Enhanced monocyte tissue factor response after experimental balloon angioplasty in hypercholesterolemic rabbit: inhibition with dietary L-arginine. (1998) (47)
Prognostic significance of circulating levels of angiogenic cytokines in patients with congestive heart failure. (2005) (47)
Effects of coronary stenting on restenosis and occlusion after angioplasty of the culprit vessel in patients with recent myocardial infarction. (1997) (46)
Impact of high loading and maintenance dose of clopidogrel within the first 15 days after percutaneous coronary intervention on patient outcome. (2009) (46)
Basic fibroblast growth factor restores endothelium-dependent responses after balloon injury of rabbit arteries. (1996) (45)
Stress hyperglycaemia is an independent predictor of left ventricular remodelling after first anterior myocardial infarction in non-diabetic patients. (2006) (44)
A common variant of endothelial nitric oxide synthase (Glu298Asp) is associated with collateral development in patients with chronic coronary occlusions (2005) (43)
Restenosis after delayed coronary angioplasty of the culprit vessel in patients with a recent myocardial infarction treated by thrombolysis. (1995) (40)
Vitamin K antagonists with or without long‐term antiplatelet therapy in outpatients with stable coronary artery disease and atrial fibrillation: Association with ischemic and bleeding events (2017) (38)
Incident Myocardial Infarction and Very Late Stent Thrombosis in Outpatients With Stable Coronary Artery Disease. (2017) (37)
A systematic review and meta-regression of temporal trends in the excess mortality associated with diabetes mellitus after myocardial infarction. (2016) (37)
Morphological changes after percutaneous transluminal coronary angioplasty of unstable plaques. Insights from serial angioscopic follow-up. (1996) (36)
Deep plasma proteomic analysis of patients with left ventricular remodeling after a first myocardial infarction (2010) (36)
The effects of beta-blockers in patients with stable chronic heart failure. Predictors of left ventricular ejection fraction improvement and impact on prognosis. (2007) (36)
Prognostic importance of tissue Doppler-derived diastolic function in patients presenting with acute coronary syndrome: a bedside echocardiographic study. (2008) (35)
Coronary Thrombosis and Myocardial Bridging (2002) (35)
Serum MMP-8: A Novel Indicator of Left Ventricular Remodeling and Cardiac Outcome in Patients after Acute Myocardial Infarction (2013) (35)
Angiographically documented late reocclusion after successful coronary angioplasty of an infarct-related lesion is a powerful predictor of long-term mortality. (1999) (34)
Decreased serine207 phosphorylation of troponin T as a biomarker for left ventricular remodelling after myocardial infarction. (2011) (33)
Two‐pronged antiplatelet therapy with aspirin and ticlopidine without systemic anticoagulation: an alternative therapeutic strategy after bailout stent implantation (1995) (32)
A prospective evaluation of left ventricular remodeling after inaugural anterior myocardial infarction as a function of gene polymorphisms in the renin-angiotensin-aldosterone, adrenergic, and metalloproteinase systems. (2007) (32)
Hybrid revascularization, comprising coronary artery bypass graft with exclusive arterial conduits followed by early drug-eluting stent implantation, in multivessel coronary artery disease. (2010) (32)
Effects of stenting of recent or chronic coronary occlusions on late vessel patency and left ventricular function. (1997) (32)
Angiopeptin inhibits oncogene induction in rabbit aorta after balloon denudation. (1994) (31)
Extracellular Matrix Turnover Biomarkers Predict Long-Term Left Ventricular Remodeling After Myocardial Infarction: Insights From the REVE-2 Study (2013) (31)
Basic fibroblast growth factor increases tissue factor expression in circulating monocytes and in vascular wall. (2000) (31)
Predicting left ventricular remodeling after a first myocardial infarction by plasma proteome analysis (2008) (31)
Serum hepatocyte growth factor levels predict long-term clinical outcome after percutaneous coronary revascularization. (2005) (30)
MicroRNAs regulating superoxide dismutase 2 are new circulating biomarkers of heart failure (2017) (29)
Restenosis rate after multiple percutaneous transluminal coronary angioplasty procedures at the same site. A quantitative angiographic study in consecutive patients undergoing a third angioplasty procedure for a second restenosis. (1993) (29)
Exercise does not enhance the prognostic value of Doppler echocardiography in patients with left ventricular systolic dysfunction and functional mitral regurgitation at rest. (2008) (29)
Cardiovascular proteomics: Translational studies to develop novel biomarkers in heart failure and left ventricular remodeling (2011) (28)
Cardiac remodeling and heart failure after a first anterior myocardial infarction in patients with diabetes mellitus (2012) (28)
Polymorphisms of the tissue factor pathway inhibitor gene and the risk of restenosis after coronary angioplasty (2001) (28)
Use of human tissue specimens obtained by directional atherectomy to study restenosis. (1994) (28)
Prognostic impact of ß-blocker use in patients with stable coronary artery disease (2014) (28)
Heart ‘omics’ in AGEing (HOMAGE): design, research objectives and characteristics of the common database (2014) (27)
Long-term prognostic impact of left ventricular remodeling after a first myocardial infarction in modern clinical practice (2017) (27)
Beta‐adrenergic receptor blockade and the angiotensin‐converting enzyme deletion polymorphism in patients with chronic heart failure (2004) (27)
Long-term risk and predictors of cardiovascular death in stable coronary artery disease: the CORONOR study (2017) (27)
Role of endothelial cells in restenosis after coronary angioplasty (1996) (26)
Poor agreement between light transmission aggregometry, Verify Now P2Y12 and vasodilatator-stimulated phosphoprotein for clopidogrel low-response assessment: A potential explanation of negative results of recent randomized trials (2014) (25)
Paraoxonase polymorphism (Gln192Arg) as a determinant of the response of human coronary arteries to serotonin. (2000) (25)
Preprocedural high-sensitivity C-reactive protein predicts death or myocardial infarction but not target vessel revascularization or stent thrombosis after percutaneous coronary intervention. (2009) (25)
NO synthesis is involved in structural and functional effects of ACE inhibitors in injured arteries. (1996) (24)
High incidence of recurrent in stent thrombosis after successful treatment of a first in stent thrombosis (2008) (24)
Detection and Management of Associated Atherothrombotic Locations in Patients with a Recent Atherothrombotic Ischemic Stroke: Results of the DETECT Survey (2006) (23)
Association between the ACE genotype and coronary artery disease. Insights from studies on restenosis, vasomotion and thrombosis. (1998) (23)
Potassium channel activators in vasospastic angina. (1993) (23)
Circulating levels of hepatocyte growth factor and left ventricular remodelling after acute myocardial infarction (from the REVE‐2 study) (2011) (23)
Repeat percutaneous coronary angioplasty; clinical and angiographic follow-up in patients with stable or unstable angina pectoris. (1993) (23)
Left ventricular remodeling is associated with the severity of mitral regurgitation after inaugural anterior myocardial infarction--optimal timing for echocardiographic imaging. (2008) (22)
Dual determination of angiotensin-converting enzyme and angiotensin-II type 1 receptor genotypes as predictors of restenosis after coronary angioplasty. (1998) (22)
The impact of the AMPD1 gene polymorphism on exercise capacity, other prognostic parameters, and survival in patients with stable congestive heart failure. A study on 686 consecutive patients. (2006) (22)
Prevention of Coronary Spasm by Nicorandil: Comparison with Nifedipine (1992) (21)
Copeptin in acute coronary syndromes and heart failure management: State of the art and future directions. (2015) (21)
Images in cardiovascular medicine. Coronary thrombosis and myocardial bridging. (2002) (20)
Relation of admission white blood cell count to left ventricular remodeling after anterior wall acute myocardial infarction. (2007) (20)
Additional diagnostic value of new CT imaging techniques for the functional assessment of coronary artery disease: a meta-analysis (2019) (19)
Aspirin does not adversely affect survival in patients with stable congestive heart failure treated with Angiotensin-converting enzyme inhibitors. (2003) (19)
Is hormonal activation during exercise useful for risk stratification in patients with moderate congestive heart failure? (2004) (19)
Expression and Implication of Clusterin in Left Ventricular Remodeling After Myocardial Infarction (2018) (19)
bFGF restores endothelium-dependent responses of hypercholesterolemic rabbit thoracic aorta. (1997) (19)
Cardiac Correlates of Exercise Induced Pulmonary Hypertension in Patients with Chronic Heart Failure Due to Left Ventricular Systolic Dysfunction (2008) (19)
Growth factors and endothelial dysfunction. (1999) (19)
Angiotensin converting enzyme inhibition prevents proto‐oncogene expression in the vascular wall after injury (1995) (18)
Effects of bisoprolol in patients with stable congestive heart failure. (2004) (18)
First Hospitalization for Heart Failure in Outpatients With Stable Coronary Artery Disease: Determinants, Role of Incident Myocardial Infarction, and Prognosis. (2018) (18)
Exercise‐Induced ST‐Segment Depression in Patients Without Restenosis After Coronary Angioplasty: Relation to Preprocedural Impaired Left Ventricular Function (1994) (17)
Intramural injection of biodegradable microspheres as a local drug-delivery system to inhibit neointimal thickening in a rabbit model of balloon angioplasty. (1998) (16)
The high cost of implantable deﬁbrillators (2007) (16)
Six-month quantitative angiographic follow-up of < 50% diameter stenoses dilated during multilesion percutaneous transluminal coronary angioplasty. (1993) (16)
Influence of late reopening of the infarct-related artery on left ventricular remodelling after myocardial infarction. IRIS Study Group. (1997) (16)
ACE inhibition accelerates endothelial regrowth in vivo: a possible explanation for the benefit observed with ACE inhibitors following arterial injury. (1997) (16)
Prospective aortic screening in men with coronary aneurysms. (2006) (15)
Prognostic significance of silent myocardial ischaemia during maximal exercise testing after a first acute myocardial infarction. (1993) (15)
Circulating proteomic signature of early death in heart failure patients with reduced ejection fraction (2019) (15)
ACE polymorphism, a genetic predictor of occlusion after coronary angioplasty. (1996) (14)
Functional mitral regurgitation and chronic heart failure. (2006) (14)
Screening for asymptomatic coronary artery disease in patients with diabetes mellitus: A systematic review and meta-analysis of randomized trials (2016) (14)
Late recovery in left ventricular systolic function after discharge of patients with a first anterior myocardial infarction. (2010) (14)
Multimarker Proteomic Profiling for the Prediction of Cardiovascular Mortality in Patients with Chronic Heart Failure (2015) (14)
Strategy for purification and mass spectrometry identification of SELDI peaks corresponding to low-abundance plasma and serum proteins. (2011) (13)
L-arginine and L-NAME have no effects on the reendothelialization process after arterial balloon injury. (1999) (13)
Heparin does not inhibit oncogene induction in rabbit aorta following balloon denudation. (1993) (13)
Growth Factors as a Potential New Treatment for Ischemic Heart Disease (1997) (12)
The effect of ageing on cardiac remodelling and hospitalization for heart failure after an inaugural anterior myocardial infarction. (2008) (12)
Integrative System Biology Analyses Identify Seven MicroRNAs to Predict Heart Failure (2019) (12)
Circulating levels of soluble Fas ligand and left ventricular remodeling after acute myocardial infarction (from the REVE-2 study). (2012) (12)
Prevention of restenosis future directions. (1997) (11)
[Potential of non-coding RNA as biomarkers in heart failure]. (2015) (11)
Cytomegalovirus infection and coronary restenosis. (1999) (11)
Protective Effects of Basic Fibroblast Growth Factor in Early Atherosclerosis (2004) (11)
Association of OAZ1 Gene Polymorphisms With Subclinical and Clinical Vascular Events (2007) (10)
Increased clusterin levels after myocardial infarction is due to a defect in protein degradation systems activity (2019) (10)
PROTEOMIC ANALYSIS IN CARDIOVASCULAR DISEASES (2008) (10)
Polyarteritis nodosa-related coronary aneurysms. (2008) (10)
Hypersensitivity of human coronary segments to ergonovine 6 months after injury by coronary angioplasty: a quantitative angiographic study in consecutive patients undergoing single-vessel angioplasty. (1996) (10)
Percutaneous coronary rotary ablation. (1990) (9)
Effect of balloon inflation in angiographically normal coronary segments during coronary angioscopy: a quantitative angiographic study. (1994) (9)
Association of Mortality With Aortic Stenosis Severity in Outpatients: Results From the VALVENOR Study. (2021) (9)
Impact of Moderate Aortic Stenosis on Long-Term Clinical Outcomes: A Systematic Review and Meta-Analysis. (2022) (9)
Reaching low-density lipoprotein cholesterol treatment targets in stable coronary artery disease: Determinants and prognostic impact. (2017) (9)
ACE gene polymorphism and coronary restenosis. (1999) (8)
Myocardial metastasis of a bronchial carcinoid. (2007) (8)
Dose‐Response Curve of Angiographically Smooth Human Epicardial Vessel Segments to Intracoronary Injections of Isosorbide Dinitrate (1992) (8)
Association of ornithine transcarbamylase gene polymorphisms with hypertension and coronary artery vasomotion. (2009) (8)
Secondary prevention and outcomes in outpatients with coronary artery disease, atrial fibrillation or heart failure: a focus on disease overlap (2020) (8)
Dual antiplatelet therapy in patients with stable coronary artery disease in modern practice: prevalence, correlates, and impact on prognosis (from the Suivi d'une cohorte de patients COROnariens stables en region NORd-Pas-de-Calais study). (2014) (8)
Gene Polymorphisms and Outcome After Coronary Angioplasty. (2001) (7)
Elective Coronary Revascularization Procedures in Patients With Stable Coronary Artery Disease: Incidence, Determinants, and Outcome (From the CORONOR Study). (2018) (7)
Antithrombotic therapy in diabetic patients with coronary artery disease. (2015) (7)
[Abnormal origin of the left circumflex coronary artery: clinical, angiographic and prognostic aspects. Apropos of 30 cases]. (1992) (7)
Effect of aspirin in addition to oral anticoagulants in stable coronary artery disease outpatients with an indication for anticoagulation. (2016) (7)
L'hypertension artérielle pulmonaire primitive: une complication rare mais souvent mortelle du Crest syndrome (1997) (7)
An unusual case of papillary fibroelastoma "invading" the mitral valve. (2006) (7)
Incidence and determinants of cerebrovascular events in outpatients with stable coronary artery disease (2018) (7)
Association of Diabetic Status and Glycemic Control With Ischemic and Bleeding Outcomes in Patients With Stable Coronary Artery Disease: The 5‐Year CORONOR Registry (2018) (6)
Effect of left ventricular systolic dysfunction on secondary medical prevention and clinical outcome in stable coronary artery disease patients. (2017) (6)
951-73 Combined Antiplatelet Therapy without Anticoagulation: An Effective Alternative to Prevent Subacute Thrombosis After Coronary Stenting?A 3 Month Follow-up (1995) (6)
[Treatment of first restenosis by recurrent angioplasty. Immediate results and angiographic follow-up after 6 months]. (1992) (6)
Prognostic Significance of the Renal Resistive Index After Renal Artery Revascularization in the Context of Flash Pulmonary Edema (2015) (6)
Prevalence and correlates of non-optimal secondary medical prevention in patients with stable coronary artery disease. (2015) (6)
Gene polymorphisms of pro- (or anti-) inflammatory cytokines and vascular disease. (2001) (6)
Dual antiplatelet therapy in patients with a long coronary artery lesion over 30 mm: Determinants and impact on prognosis. (2015) (6)
Thromboaspiration dans les syndromes coronaires aigus par le système RESCUE (2004) (5)
Accuracy of cardiac magnetic resonance imaging to rule out significant coronary artery disease in patients with systolic heart failure of unknown aetiology: Single-centre experience and comprehensive meta-analysis. (2018) (5)
Decreased Serine 207 phosphorylation of troponin T as a biomarker for left ventricular remodelling after myocardial infarction (2010) (5)
Angiotensin II receptor blockers versus angiotensin-converting enzyme inhibitors in patients with stable coronary artery disease: Prevalence, correlates, and prognostic impact (from the CORONOR study). (2017) (5)
Sunday, 26 August 2012 (2012) (5)
Incidence, determinants and consequences of left atrial remodelling after a first anterior myocardial infarction. (2012) (5)
Resténose après angioplastie coronaire : apport des modèles expérimentaux (1993) (5)
Secondary medical prevention and clinical outcome in coronary artery disease patients with a history of non-coronary vascular intervention: A report from the CORONOR investigators (2015) (5)
New technologies, new therapies: toward personalized medicine in heart failure patients? (2013) (5)
Impact of thrombus aspiration use and direct stenting on final myocardial blush score in patients presenting with ST-elevation myocardial infarction. (2010) (5)
Practice Patterns for Outpatients With Stable Coronary Artery Disease: A Case Vignette-based Survey Among French Cardiologists (2015) (5)
[Intravenous thrombolysis by recombinant plasminogen activator (rt-PA) in unstable angina. A randomized multicenter study versus placebo]. (1992) (5)
Clopidogrel Use as Single Antiplatelet Therapy in Outpatients with Stable Coronary Artery Disease: Prevalence, Correlates and Association with Prognosis (from the CORONOR Study) (2016) (5)
Morphological changes of coronary stenosis after repeated balloon angioplasties: a quantitative angiographic study. (1991) (4)
White blood cell and peripheral blood mononuclear cell counts for the prediction of left ventricular remodeling after myocardial infarction. (2011) (4)
[From the angiogenic response to ischemia to the validation of the concept of "therapeutic angiogenesis"]. (1998) (4)
Angioplasty in the diabetic patient. (2004) (4)
Angiotensin Converting Enzyme and Angiotensin II Type 1 Receptor Polymorphisms in Patients with Coronary Aneurysms (2003) (4)
Letter by Pinet et al Regarding Article, "Comparative Analysis of Circulating Noncoding RNAs Versus Protein Biomarkers in the Detection of Myocardial Injury". (2019) (4)
No gender survival difference in a population of patients with chronic heart failure related to left ventricular systolic dysfunction and receiving optimal medical therapy. (2008) (4)
Correlation Between Chlamydia pneumoniae Detection From Coronary Angioplasty Balloons and Atherosclerosis Severity (2006) (4)
Relative Importance of Heart Failure Events Compared to Stroke and Bleeding in AF Patients (2021) (4)
An open multicenter registry to evaluate local heparin delivery following balloon angioplasty for the prevention of restenosis: preliminary results (1996) (4)
Long-term prognostic value of preprocedural adiponectin levels in patients undergoing percutaneous coronary intervention. (2013) (4)
The impact of the AMPD1 gene polymorphism on exercise capacity, other prognostic parameters, and survival in patients with stable congestive heart failure: a study in 686 consecutive patients. (2006) (4)
Relative prognostic value of clinical, exercise, and angiographic data after a first myocardial infarction (1993) (4)
Simple risk models to predict cardiovascular death in patients with stable coronary artery disease (2020) (4)
Restenosis after coronary angioplasty for rapidly progressive coronary stenosis. (1996) (4)
Real-Life Incident Atrial Fibrillation in Outpatients with Coronary Artery Disease (2020) (4)
[Restenosis after angioplasty]. (1999) (4)
[Vasomotor activity and coronary insufficiency]. (1991) (4)
Long-term OralAdministration ofL-Arginine Reduces Intimal Thickening andEnhances Neoendothelium-Dependent Acetylcholine-In duced Relaxation After Arterial Injury (1994) (4)
Nature of coronary disease in patients with insulin resistance and its impact on revascularization strategies (2005) (3)
Integrative network analysis reveals time-dependent molecular events underlying left ventricular remodeling in post-myocardial infarction patients. (2017) (3)
Prognostic value of changes in R-wave amplitude during exercise testing after a first acute myocardial infarction. (1992) (3)
Abstract 2914: Serum Uric Acid is a Powerful Predictor of Survival in Patients With Stable Chronic Heart Failure Receiving Beta-Blocker Therapy (2007) (3)
Prognostic values of exercise echocardiography and cardiopulmonary exercise testing in patients with primary mitral regurgitation. (2021) (3)
Procedural variables associated with eventual long term angiographic success in patients with recurrent restenosis. (1991) (3)
Vasomotricité et insuffisance coronaire. (1991) (3)
Augmentation de l'expression des oncogènes c-myc et c-fos en fonction de l'activité mécanique du cœur isolé de rat adulte (1988) (3)
Echocardiographic diastolic function evolution in patients with an anterior Q‐wave myocardial infarction: insights from the REVE‐2 study (2018) (3)
Gender differences in clinical characteristics, medical management, risk factor control, and long-term outcome of patients with stable coronary artery disease: from the CORONOR registry. (2020) (2)
Tissue factor predicts long-term outcome after percutaneous coronary revascularization (2003) (2)
Prospective assessment of multiple cardiac papillary fibroelastomas: an echocardiographic and surgical study. (2010) (2)
156: Prevalence, determinants and prognosis value of right ventricular function impairment in organic mitral regurgitation (2013) (2)
Apolipoprotein Proteomic Profiling for the Prediction of Cardiovascular Death in Patients with Heart Failure (2020) (2)
Rotational atherectomy — An overview (1994) (2)
Thérapie cellulaire et insuffisance cardiaque (2003) (2)
[Air pollution]. (2016) (2)
MicroRNAs as Circulating Biomarkers of Left Ventricular Remodeling after Myocardial Infarction (2016) (2)
Relative impact of bleedings over ischaemic events in patients with heart failure: insights from the CARDIONOR registry (2020) (2)
Dosing Strategies for Antiplatelet Therapy in Percutaneous Coronary Intervention (2010) (2)
Extracellular matrix turnover biomarkers predict left ventricular remodeling after myocardial infarction (insights from the REVE-2 study) (2013) (2)
[Endothelial dysfunction in cardiovascular diseases: therapeutic implications after coronary angioplasty]. (1997) (2)
Utility and safety of coronary angiography in patients with acute infective endocarditis who required surgery. (2020) (2)
Silent coronary plaque rupture. (2008) (2)
Gene therapy for cardiovascular diseases. (1995) (2)
[Predictive factors of primary success after coronary angioplasty. Qualitative and quantitative angiography of 3679 coronary stenosis before and after dilatation]. (1994) (2)
Diabetes mellitus and cardiovascular mortality across the spectrum of aortic stenosis (2022) (2)
Mechanical recanalization of coronary arteries (1991) (2)
Coronary angioscopy — An inner view (1994) (2)
[The use of the RESCUE thromboaspiration system in acute coronary syndrome]. (2004) (2)
Oral Abstract Session * New insights into primary mitral regurgitation: Valvular heart disease associated with systemic conditions and others (2012) (2)
[Percutaneous coronary angioscopy: 200 observations in 100 candidates for angioplasty]. (1995) (1)
Impact of initial clinical presentation on clopidogrel low response. (2013) (1)
Restnose et rponse de la paroi vasculaire aprs angioplastie: aspects physiopathologiques (2004) (1)
Données récentes sur la plaque d'athérome et son évolution (1998) (1)
, Failure Circulating Long Noncoding RNA , LIPCAR , Predicts Survival in Patients With Heart (1)
[Restenosis after coronary angioplasty. Contribution of experimental models]. (1993) (1)
Athérothrombose : un même processus pour différents territoires artériels ? (2002) (1)
Left ventricular remodeling and heart failure after myocardial infarction in elderly patients. (2010) (1)
[Long-term prognosis after myocardial infarction. Value of exercise test compared to clinical features and coronarography]. (1991) (1)
[Coronary angioplasty of multivessel coronary diseases. Apropos of 1664 procedures. Immediate results and results following 6 months]. (1992) (1)
Tissue factor inhibition impairs the maturation of neovascularization in postnatal angiogenesis (2002) (1)
Dysfonction endothéliale en pathologie cardiovasculaire : implications thérapeutiques après angioplastie coronaire (1997) (1)
Compared Impact of Diabetes on the Risk of Heart Failure from Acute Myocardial Infarction to Chronic Coronary Artery Disease. (2021) (1)
Long term risk/benefit of PTCA of infarct related vessel (1991) (1)
Right heart catheterization in advanced systolic heart failure. What are the most useful haemodynamic parameters for risk stratification? (2022) (1)
Angor à coronaires angiographiquement normales (1991) (1)
Cœur et pollution particulaire (2016) (1)
[Stenosis of the common trunk of the left coronary artery: an unusual complication of percutaneous coronary angioplasty]. (1992) (1)
[Cell therapy to treat heart failure]. (2003) (1)
Angiogenèse et facteurs de croissance endothéliaux : une nouvelle voie thérapeutique ? (1997) (1)
Evaluation of screening for myocardial ischaemia in women at cardiovascular risk. (2017) (1)
Six month clinical and angiographic follow-up of stenting without anticoagulation: The Ticlopidine Aspirin Stent Evaluation (TASTE) study (1996) (1)
The D Allele of the Angiotensin I Converting Enzyme Is Associated With Diffuse In-stent Restenosis (1998) (1)
Impact of the adjunction of aspirin on top of oral anticoagulants in stable coronary artery disease outpatients with an indication for anticoagulation. (2016) (1)
Delayed recovery of left ventricular systolic dysfunction: ''give time to medical therapy''. (2007) (1)
Quantitative assessment of the residual stenosis after percutaneous transluminal cororonary rotary ablation: European Experience (1993) (1)
1012-103 Restoration of Endothelial Function in Hypercholesterolemic Rabbit by Intermittent Administration of Vascular Endothelial Growth Factor (1995) (1)
934-28 Sensitivity and Specificity of Angiographic Markers for Thrombus: A Prospective Comparison with Angioscopy (1995) (1)
[Primary pulmonary hypertension: a rare but often fatal complication of Crest syndrome]. (1997) (1)
Prognostic significance of reverse dipping status on lower limb event in type 2 diabetic patients without peripheral arterial disease (2022) (1)
Protéomique et marqueurs cardiaques (2007) (1)
[Recanalization of complete coronary occlusions followed by STENT implantation. An angiographic study after 6 months]. (1997) (1)
H034 Rôle pronostique à long terme de l’aldostérone plasmatique dans l’angioplastie coronaire non urgente (2009) (0)
Jndications des képarines de bas poids moléculaire en pratique clinique en cardiologie (2005) (0)
Angiogenèse thérapeutique en pathologie artérielle : état des lieux (2004) (0)
Quand faut-il coronarographier un infarctus du myocarde? (1993) (0)
réponse des artères coronaires à l'injection intracoronaire de dinitrate d'isosorbide : établissement d'une courbe dose-réponse (1992) (0)
Lu revascularisation myocardique chez le patient diabétique : la place de l'angioplastie coronaire (2005) (0)
Expression des oncogenes nucleaires c-myc et c-fos dans les surcharges hemodynamiques du coeur de rat adulte (1990) (0)
L'ischémie silencieuse (1994) (0)
Iconographies supplémentaires de l'article : Cœur et pollution particulaire (2016) (0)
Jnsuffisance rénale et infarctus du myocarde (2005) (0)
L'angiographie du ventricule gauche (1993) (0)
La cardiopathie ischémique du diabétique : quelle spécificité, comment l’explorer, quelle revascularisation ? (2008) (0)
B-type natriuretic peptide for the prediction of left ventricular remodelling (2014) (0)
633 Improvement of the comprehensive analysis of mitral regurgitant jet with live three-dimensional color-flow doppler (2006) (0)
[Evaluation of the anesthetic risk in patients with coronary disease prior to non-cardiac surgery]. (1993) (0)
[Indications and limits of myocardial revascularization in the elderly]. (2006) (0)
01-9 - REAL-TIME THREE-DIMENSIONAL COLOR-FLOW DOPPLER IMPROVES THE COMPREHENSIVE ANALYSIS OF MITRAL REGURGITANT JET (2008) (0)
Abstract 2372: Hemoglobin A1c Levels are Associated with Severity and Prognosis of Systolic Chronic Heart Failure in Non Diabetic Patients (2006) (0)
Poster session I * Thursday 9 December 2010, 08:30-12:30 (2010) (0)
Contents Vol. 133, 2016 (2016) (0)
Prise en charge de l'IC en post-infarctus 2006 (2006) (0)
[Coronary angioplasty in diabetic patients. Analysis of the problems to improve results]. (1999) (0)
[Restenosis and vascular response after angioplasty: physiopathological data]. (2004) (0)
Restenotic process and DD genotype after angiotensin-converting enzyme inhibitor treatment (2001) (0)
[Angina pectoris. Epidemiology, etiology, physiopathology, diagnosis, course, treatment]. (1996) (0)
NATURAL HISTORY OF INFARCT-RELATED LESIONS. AUTHORS' REPLY (1998) (0)
Very long-term outcomes of older adults with stable coronary artery disease (from the CORONOR study) (2021) (0)
Late vessel occlusion is a frequent mode of restenosis after balloon angioplasty in diabetic patients (1998) (0)
Expression of nuclear oncogenes in rabbit aorta after balloon denudation (1991) (0)
MicroRNAs regulating superoxide dismutase 2 are new circulating biomarkers of heart failure (2017) (0)
027: Predictors factors of severe coronary artery disease in an Algerian population (2014) (0)
Publisher Correction: MicroRNAs regulating superoxide dismutase 2 are new circulating biomarkers of heart failure (2018) (0)
[Angiography of the left ventricle]. (1993) (0)
0053 : Short-term moderate diet restriction in adulthood can reverse alterations of cardiac function induced by postnatal overfeeding in mice (2015) (0)
[Nitrate derivatives and coronary vasomotricity]. (1992) (0)
Evaluation of right ventricular function in patients with organic mitral regurgitation (2011) (0)
[Myocardial revascularization in silent myocardial ischemia]. (1993) (0)
[Atheroma. Epidemiology and physiopathology of multiple atheromatosis]. (2003) (0)
Utility and safety of systematic coronary angiogram in patients with acute infective endocarditis who required surgery: Single centre experience and comprehensive meta-analysis (2021) (0)
[Atherothrombosis: the same process for different arterial territories?]. (2002) (0)
High-sensitivity C-reactive protein: potential adjunct for risk stratiﬁcation in patients with stable congestive heart failure (2005) (0)
[Is there a role for calcium antagonists when beta-adrenergic blockade therapy is contraindicated in post-myocardial infarction?]. (2006) (0)
[Does diabetes affect therapy in coronary patients? Revascularisation]. (2004) (0)
[Other techniques of arterial recanalization]. (1990) (0)
[Current data on atheromatous plaques and their evolution]. (1998) (0)
Abstract 4449: Impact of High Loading and Maintenance Dose of Clopidogrel within the First 15 Days after Percutaneous Coronary Intervention on Early Patient Outcome (2008) (0)
0190: Dual antiplatelet therapy in stable patients with coronary artery disease in modern practice: prevalence, correlates and impact on prognosis (from the coronor study) (2015) (0)
[Long-term management of coronary patients: current guidelines and practices]. (2007) (0)
Oncogenes after Angioplasty (1997) (0)
[Coronary angioscopy]. (1997) (0)
Characterisation of peripartum cardiomyopathy by cardiac magnetic (2008) (0)
Iconographies supplémentaires de l'article : Accuracy of cardiac magnetic resonance imaging to rule out significant coronary artery disease in patients with systolic heart failure of unknown aetiology: Single-centre experience and comprehensive meta-analysis (2018) (0)
BBADIS-16-507-R1 1 Integrative network analysis reveals time-dependent molecular events underlying left ventricular remodeling in post-myocardial infarction patients (2020) (0)
Correlation Between Chlamydia pneumoniae Detection From and Atherosclerosis Severity (2016) (0)
[Complications of atherosclerotic plaques]. (1999) (0)
Identification of patient subtypes based on protein expression for prediction of heart failure after myocardial infarction (2023) (0)
0192: A proteomic score improves risk stratification in stable chronic heart failure patients (2015) (0)
[Should moderate coronary stenosis be dilated in patients with multi-vessel disease?]. (1993) (0)
that this should be the focus of addi- tional research. (2009) (0)
Coronary Angiography, Angioscopy, and Intravascular Ultrasound in Non‐ST‐Segment Elevation Acute Coronary Syndromes (2009) (0)
0045 : Rest and exercise pulmonary hypertension in hypertrophic cardiomyopathy (2015) (0)
A special thanks to our Ad hoc reviewers (1999) (0)
Abstract 1893: Impact of the Glu298Asp Polymorphism of the Endothelial Nitric Oxide Synthase Gene on Prognostic Parameters and on Survival in 684 Consecutive Patients With Stable Congestive Heart Failure (2006) (0)
1103-165 Serum levels of angiogenic growth factors predict long-term clinical outcome after percutaneous coronary revascularization (2004) (0)
Fasting plasma insulin is an independent predictor of cardiac events at one year after percutaneous coronary revascularization (2003) (0)
Hospitalization for heart failure in stable coronary artery disease outpatients: determinants, role of interim myocardial infarction, and prognosis (2017) (0)
1072 Primary hemostasis impairment at rest as a surrogate biomarker of baseline or latent obstruction in hypertrophic cardiomyopathy: an exercise echocardiographic study (2005) (0)
Incidence, Source, Determinants, And Prognostic Impact Of Major Bleeding In Outpatients With Chronic Heart Failure: Insights From The CARDIONOR Registry (2019) (0)
[The genetics of multifactorial cardiovascular disease. How significant for the cardiologist?]. (2003) (0)
Le patient coronarien fragile (2006) (0)
021: Clopidogrel low response and correlation between the different tests: light transmission aggregometry, VerifyNow-P2Y12 and V ASP (2013) (0)
Apolipoprotein screening by LC-MRM-MS for the prediction of cardiovascular death in patients with chronic systolic heart failure (2019) (0)
Clinical significance of myocardial work parameters after acute myocardial infarction (2022) (0)
940-72 Effect of Late Coronary Angioplasty of an Infarct-related Vessel on Left Ventricular Function (1995) (0)
Abstract 13415: Is Late Gadolinium Enhancement by Cardiac Magnetic Resonance Really Helpful for Risk Stratification in Patients With Stable Heart Failure in Comparison With Usual Prognostic Factors ? (2010) (0)
High-sensitivity C-reactive protein for risk stratification in patients with heart failure. (2008) (0)
[Endothelin-1 receptor antagonists in heart failure]. (2003) (0)
Evaluation of the management of acute coronary syndrome without ST-segment elevation: Impact of the invasive strategy delay, a monocentre study (2019) (0)
[Acute atherothrombotic accidents: plaque and thrombosis rupture]. (2002) (0)
Abstract 3134: Aldosterone A Major Determinant Of Long Term Mortality in Elective PCI (2007) (0)
104 Latent obstruction elicits a rapid proteolysis of von Willebrand factor in patients with hypertrophic cardiomyopathy. A rest and exercise echocardiographic study (2010) (0)
Abstract 3473: Stress Hyperglycemia is an Independent Predictor of Left Ventricular Remodeling After Inaugural Anterior Myocardial Infarction in non Diabetic Patients (2006) (0)
[What is the place of beta-adrenergic blockade therapy in coronary syndromes in the modern management era?]. (2006) (0)
1060 Factors associated with pulmonary artery pressure rise in mitral regurgitation related to valve prolapse (2006) (0)
Nuclear oncogenes are induced in rabbit aorta after balloon denudation (1991) (0)
Apolipoprotein ciii and triglyceride correlate with the necrotic core of a lesion plaque in patients with stable coronary disease (0)
Management of antithrombotics in situations with a gap in evidence: A national French survey focusing on patients with coronary artery disease and atrial fibrillation (2021) (0)
Abstract 3734: Live Three-Dimensional Color-Flow Doppler Improves the Comprehensive Analysis of Mitral Regurgitant Jet (2006) (0)
Abstract 18304: Prognostic Value of Right Ventriclular EchoDoppler Parameters in Patients With Left Ventricular Systolic Dysfunction: Comparison to Radionuclide Right Ventricular Ejection Fraction (2010) (0)
Publisher Correction: MicroRNAs regulating superoxide dismutase 2 are new circulating biomarkers of heart failure (2018) (0)
Growth factors and endothelial dysfunction. (1999) (0)
[Endovascular ultrasonography. A technology with a promising future]. (1993) (0)
Impact of initial clinical presentation on clopidogrel low response: is there any intra-individual variability over time? (2012) (0)
[Relation between progression of atherosclerosis and the phenomenon of restenosis after coronary angioplasty]. (1996) (0)
Abstract n°46 - LEFT ATRIAL VOLUME AND LEFT VENTRICULAR DIASTOLIC PARAMETERS PREDICT PULMONARY ARTERY PRESSURE LEVEL IN MITRAL REGURGITATION RELATED TO VALVE PROLAPSE (2008) (0)
968-30 Does Insertion/Deletion Polymorphism of the Angiotensin Converting Enzyme Influence the Occurrence of Restenosis After Percutaneous Transluminal Coronary Angioplasty? (1995) (0)
0282: Rest and exercise pulmonary hypertension in hypertrophic cardiomyopathy (2016) (0)
Association ofangiotensin converting enzymeand angiotensin IItype1receptor genotypes withleft ventricular function andmassinpatients with angiographically normal coronary arteries (1997) (0)
Incidence and timing of left ventricular reverse remodeling: Key information for the management of patients with new onset left ventricular systolic dysfunction. (2016) (0)
Proteomic signature for early diagnosis of left ventricular remodeling after myocardial infarction (2020) (0)
Serotonin After Injury by Coronary Angioplasty (2005) (0)
0132 : Usefulness of multiple proteinchip arrays for proteomic profiling using surface enhanced laser desorption ionization – time of flight – mass spectrometry (SELDI-TOF-MS) (2015) (0)
[Response of coronary arteries to the intracoronary injection of isosorbide dinitrate. Dose-response curve]. (1992) (0)
025: Impact of initial clinical presentation on clopidogrel low response: is there any intra-individual variability over time? (2013) (0)
Additional file 2: Figure S1. of Screening for asymptomatic coronary artery disease in patients with diabetes mellitus: A systematic review and meta-analysis of randomized trials (2016) (0)
Identification of patients subtypes based on protein expression for prediction of heart failure after myocardial infarction (2021) (0)
060 Plasma aldosterone levels predict long-term clinical outcome after percutaneous coronary revascularization (2010) (0)
Model of Lower Limb Vascular Insufficiency (2007) (0)
Les accidents athérothrombotiques aigus : rupture de plaque et thrombose (2002) (0)
Incidence, Source, and Prognostic Impact of Major Bleeding Across the Spectrum of Aortic Stenosis. (2023) (0)
Elective Coronary Revascularization Procedures in Patients With StableCoronary Artery Disease (2018) (0)
Dual determination of angiotensin-converting enzyme and angiotensin-II type 1 receptor genotypes as predictor of restenosis after coronary angioplasty (1996) (0)
Vascular endothelial growth factor and arterial disease (1997) (0)
Iconographies supplémentaires de l'article : 060 - Plasma aldosterone levels predict long-term clinical outcome after percutaneous coronary revascularization (2010) (0)
Clopidogrel low response and correlation between the different tests: light transmission aggregometry, VerifyNow P2Y12, and VASP (2012) (0)
Génétique des paragangliomes tympano-jugulaires opérés : implication sur la prise en charge (2014) (0)
Vulnérabilité et instabilité : les liens entre l'athérosclérose et ses complications (2006) (0)
Silent coronary plaque rupture Rupture silencieuse de plaque coronaire (2008) (0)
Le diabète influence-t-il les choix thérapeutiques chez le coronarien ? La revascularisation (2004) (0)
Prise en charge à long terme des patients coronariens: recommandations actuelles et pratique clinique (2007) (0)
L’insuffisance mitrale fonctionnelle : reflet d’une maladie ventriculaire gauche dynamique, mécanismes de repos et d’effort (2006) (0)
Quelle est la place des inhibiteurs calciques lorsque les bêta-bloquants sont contre-indiqués dans le traitement du post-infarctus du myocarde ? (2006) (0)
Évaluation en pratique quotidienne des lésions athérothrombotiques associées chez des patients hospitalisés pour infarctus cérébral récent (2005) (0)
Un nouveau biomarqueur post-infarctus: une forme phosphorylée de la troponine T (2011) (0)
Jnsuffisance cardiaque et diabète (2004) (0)
Athérosclérose maladie plurifocale (2001) (0)
Facteur de croissance endothélial vasculaire (VEGF) et pathologie artérielle (1997) (0)
Vingt ans de progrès dans la prise en charge de la maladie coronaire (2003) (0)
Facteurs de la resténose : deux composantes et donc deux cibles pour la prévention future (1996) (0)
codants comme biomarqueurs l'insuffisance (2015) (0)
Bénéfices additionnels de l'association pravastatine et aspirine sur la réduction des événements cardiovasculaires chez le patient coronarien (2006) (0)
H004 Recherche de biomarqueurs circulants du remodelage cardiaque après infarctus par analyse protéomique (2009) (0)
[Not Available]. (2006) (0)
Indications et limites de la revascularisation myocardique chez le sujet âgé. (2006) (0)
Dérivés nitrés et vasomotricité coronaire. (1992) (0)
Insuffisance cardiaque : intérêt du suivi des patients à leur sortie de l'hôpital (2008) (0)
Traitement de la resténose en 1996 (1996) (0)
Facteurs de croissance et dysfonction endoth??liale (1999) (0)
La revascularisation du patient multitronculaire : quoi de neuf ? (2002) (0)
Physiopathologie de la maladie des artères coronaires (2008) (0)
Bêta-bloquants et syndromes coronariens: les réponses d'hier s'appliquent-elles aux stratégies d'aujourd'hui? (2006) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Christophe Bauters?

Christophe Bauters is affiliated with the following schools:

Christophe Bauters's Academic­Influence.com Rankings

Christophe Bauters's Degrees

Similar Degrees You Can Earn

Why Is Christophe Bauters Influential?

Christophe Bauters's Published Works

Published Works

What Schools Are Affiliated With Christophe Bauters?

Christophe Bauters's AcademicInfluence.com Rankings